Novel Use Of Hydroxyurea in an African Region With Malaria

PHASE3CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2017

Conditions
Sickle Cell AnemiaSickle Cell DiseaseMalaria
Interventions
DRUG

Hydroxyurea

DRUG

Placebo

Trial Locations (1)

Unknown

Mulago Hospital Sickle Cell Clinic, Kampala

All Listed Sponsors
collaborator

Doris Duke Charitable Foundation

OTHER

collaborator

Makerere University

OTHER

collaborator

Mulago Hospital, Uganda

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

Indiana University

OTHER

NCT01976416 - Novel Use Of Hydroxyurea in an African Region With Malaria | Biotech Hunter | Biotech Hunter